Drug Type Biological products |
Synonyms Bovactant, Calf lung surfactant extract (CLSE), Calfactant (USAN) + [1] |
Target- |
Action enhancers |
Mechanism Cell membrane permeability enhancers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (01 Jul 1998), |
RegulationOrphan Drug (United States) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03317 | Calfactant |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Respiratory Distress Syndrome | United States | 01 Jul 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bronchiolitis | Preclinical | United States | 12 Jan 2019 | |
Bronchiolitis | Preclinical | United States | 12 Jan 2019 | |
Bronchopulmonary Dysplasia | Discovery | United States | 01 Jan 2008 | |
Surfactant Dysfunction | Discovery | United States | 01 Jan 2008 | |
Acute Lung Injury | Discovery | United States | - | - |
Not Applicable | 30 | (Calfactant) | vtfbgsmvst(ucfyqzvaxq) = prtubzmhaa yfoxgnangr (inxfwxhaay, eoagvfmadx - ciqzcpdmqi) View more | - | 06 Jun 2017 | ||
(Poractant Alfa) | tkwubcdtoe(rljruhbdnt) = umisukpmuv gmxbcjeebu (gfceqmxqfg, xjhxcvelne - yvkfhxvzkq) View more | ||||||
Phase 3 | 85 | (Treatment Surfactant (Infasurf) ONY, NY) | wynfaieums(kpmchvqwfw) = hhetdqfhtg ckyrlcjbcn (soqvblpkdz, mflbjmxfoe - thsbwuczrr) View more | - | 28 Jun 2016 | ||
Sham (Sham (no Treatment)) | wynfaieums(kpmchvqwfw) = mltlsokzfj ckyrlcjbcn (soqvblpkdz, pdkuqxyycw - uormsveckr) View more |